Sickle Cell Anemia Pipeline Highlights - 2018

  • ID: 4516414
  • Report
  • Fore Pharma
1 of 3
The latest report Sickle Cell Anemia Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Sickle Cell Anemia market. It covers emerging therapies for Sickle Cell Anemia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Sickle Cell Anemia pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Sickle Cell Anemia pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Sickle Cell Anemia pipeline products by the company.

Short-term Launch Highlights:
Find out which Sickle Cell Anemia pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Sickle Cell Anemia phase 3 clinical trial pipeline products
  • Sickle Cell Anemia phase 2 clinical trial pipeline products
  • Sickle Cell Anemia phase 1 clinical trial pipeline products
  • Sickle Cell Anemia preclinical research pipeline products
  • Sickle Cell Anemia discovery stage pipeline products
  • Sickle Cell Anemia pipeline products short-term launch highlights
Note: Product cover images may vary from those shown
2 of 3
1. Sickle Cell Anemia Pipeline by Stages
2. Sickle Cell Anemia Pipeline by Drug Class
3. Sickle Cell Anemia Pipeline by Company
4. Sickle Cell Anemia Phase 3 Clinical Trial Insights
5. Sickle Cell Anemia Phase 2 Clinical Trial Insights
6. Sickle Cell Anemia Phase 1 Clinical Trial Insights
7. Sickle Cell Anemia Preclinical Research Insights
8. Sickle Cell Anemia Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Sickle Cell Anemia Phase 3 Clinical Trials, 2018
Table 2: Sickle Cell Anemia Phase 2 Clinical Trials, 2018
Table 3: Sickle Cell Anemia Phase 1 Clinical Trials, 2018
Table 4: Sickle Cell Anemia Preclinical Research, 2018
Table 5: Sickle Cell Anemia Discovery Stage, 2018

List of Figures
Figures 1: Sickle Cell Anemia Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Sickle Cell Anemia Pipeline Molecules by Drug Class, 2018
Figure 3: Sickle Cell Anemia Pipeline Molecules by Company, 2018
Figure 4: Sickle Cell Anemia Phase 3 Clinical Trial Highlights, 2018
Figure 5: Sickle Cell Anemia Phase 2 Clinical Trial Highlights, 2018
Figure 6: Sickle Cell Anemia Phase 1 Clinical Trial Highlights, 2018
Figure 7: Sickle Cell Anemia Preclinical Research Highlights, 2018
Figure 8: Sickle Cell Anemia Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll